EN HU

Vass Virág

Vass Virág

Publication list

2024
1.
Tósaki, Á., Szabó, Z., Király, J., Lőrincz, E. B., Vass, V., Tánczos, B., Bereczki, I., Herczegh, P., Remenyik, É., Tósaki, Á., Szabó, E.: A new cannabigerol derivative, LE-127/2, induces autophagy mediated cell death in human cutaneous melanoma cells.
Eur. J. Pharm. Sci. 203, 1-15, (article identifier: 106920), 2024.
Journal metrics:
Q1 Pharmaceutical Science (2023)
2.
Tánczos, B., Vass, V., Szabó, E., Lovas, M., Kattoub, R. G., Bereczki, I., Borbás, A., Herczegh, P., Tósaki, Á.: Effects of H2S-donor ascorbic acid derivative and ischemia/reperfusion-induced injury in isolated rat hearts.
Eur. J. Pharm. Sci. 195, 1-15, (article identifier: 106721), 2024.
Journal metrics:
Q1 Pharmaceutical Science (2023)
2023
3.
Vass, V., Szabó, E., Bereczki, I., Debreczeni, N., Borbás, A., Herczegh, P., Tósaki, Á.: Reperfusion-induced injury and the effects of the dithioacetate type hydrogen sulfide donor ibuprofen derivative, BM-88, in isolated rat hearts.
Eur. J. Pharm. Sci. 185, 1-14, (article identifier: 106449), 2023.
Journal metrics:
Q1 Pharmaceutical Science
DEENK University of Debrecen
© 2012 University of Debrecen